Over the past three decades, the scientific and medical communities have dedicated extensive research to understanding the effects of telomerase, an enzyme with remarkable implications for ageing, longevity, and various diseases. Despite initial scepticism surrounding its potential, the wealth of evidence has progressively demonstrated the profound impact of telomerase on cellular health and the ageing process.
In the early 1980s, Dr. Elizabeth Blackburn and Dr. Carol W. Greider made a groundbreaking discovery by identifying telomerase, an enzyme in pond scum, responsible for maintaining the length of telomeres. Telomeres are protective caps at the ends of chromosomes that shorten as cells divide, leading to cellular ageing and senescence. This discovery laid the foundation for decades of research into the effects of telomerase.
In the early-to-mid 1990s, while at Geron Corporation, Dr. Bill Andrews led the research to discover both the RNA and protein components of the enzyme telomerase in the human genome. Able to prevent telomeres from shortening in human reproductive cells, this is why our children are born younger than we are even though they come from our old cells. This discovery was so significant that it triggered the Nobel prize for medicine in 2009 to be awarded.
Since the discovery of human telomerase, numerous studies have explored its role in cellular ageing. Researchers have consistently observed that telomerase activation can prevent or delay telomere shortening, effectively slowing down the ageing process in cultured cells. Additionally, experiments by Dr Ronald Depino at Harvard University have shown that over-expressing telomerase can extend lifespan.
Telomere shortening is closely associated with age-related diseases and extensive research has linked telomerase deficiency to an increased risk of developing such conditions as cardiovascular disease, diabetes, and cancer. Conversely, studies have demonstrated that telomerase activation can protect against age-related diseases and improve overall health. For instance, a study published in Nature Medicine in 2010 showed that telomerase activation reversed age-related heart disease.
In recent years telomerase has also been implicated in regenerative medicine. Studies have shown that telomerase activation can promote tissue repair and regeneration, leading to faster healing and improved outcomes.
Emerging research suggests a connection between telomere length and mental health. Chronic stress, depression, and other mental health conditions have been associated with accelerated telomeres shortening and interventions such as mindfulness, meditation and exercise, which reduce stress and improve mental well-being, have been linked to longer telomeres.
The last 30 years of scientific and medical research have provided overwhelming evidence supporting the effects of telomerase on cellular health, ageing, and various diseases. Telomerase has emerged as a crucial player in understanding the ageing process and holds immense potential for combating age-related diseases and improving human health. The journey to fully unlock its capabilities and translate them into clinical applications is ongoing, but the foundation of evidence is strong.
Still not convinced? Click on any of the studies below to find out more: